Janus Henderson Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Hold |
26,200
| – | – | ﹤0.01% | 2172 |
|
|
2025
Q1 | $318K | Hold |
26,200
| – | – | ﹤0.01% | 2179 |
|
|
2024
Q4 | $494K | Hold |
26,200
| – | – | ﹤0.01% | 2041 |
|
|
2024
Q3 | $588K | Hold |
26,200
| – | – | ﹤0.01% | 1954 |
|
|
2024
Q2 | $547K | Buy |
+26,200
| New | +$547K | ﹤0.01% | 1946 |
|
|
2023
Q4 | – | Sell |
-12,933
| Closed | -$102K | – | 2588 |
|
|
2023
Q3 | $102K | Buy |
12,933
+10
| +0.1% | +$79 | ﹤0.01% | 2514 |
|
|
2023
Q2 | $129K | Sell |
12,923
-31
| -0.2% | -$310 | ﹤0.01% | 2542 |
|
|
2023
Q1 | $115K | Buy |
+12,954
| New | +$115K | ﹤0.01% | 2605 |
|